-
Early Trials Show Responses for Some Blood Cancers
First results from two clinical trials testing the safety of natural killer cell therapies show responses by patients with some forms of blood-related cancers.
-
How To Be Different in Business
Customers first must discover you, notice you, and want to buy from you before they know that you’re an excellent choice.
-
Infographic – US Biotech Venture Deals Slow in Q1
The rate of new venture deals for biotechnology start-ups in the U.S. slowed in the first quarter of 2022, but total dollars invested remain on track from last year.
-
Ginkgo Acquires Bayer Agricultural Biologics Technology
Synthetic biology developer Ginkgo Bioworks is acquiring agricultural biologics assets from Bayer, transforming the companies’ five-year partnership.
-
Post removed
Sponsored post removed for non-payment. * * *
-
Health Blockchain Start-Up Raises $5.5M in Seed Funds
A new enterprise aggregating and securing a wide range of health care data with blockchain technology is raising $5.5 million in seed funds.
-
Trial Begins Testing Crispr Gut Microbiome Therapy
A clinical trial is underway assessing a genetically edited oral drug designed to remove E. coli in the gut, a danger for patients with blood-related cancers.
-
Cystic Fibrosis Start-Up Raises $111M in New Funds
A developer of new treatments for the inherited lung disease cystic fibrosis emerged from stealth mode, raising $111 million in new venture funds.
-
Trial Set for Gut Infection Biologic Treatment
A developer of biologic therapies for gastrointestinal disorders says FDA cleared its request for a clinical trial testing its treatment for C. difficile.
-
Infographic – Chill Descends on Q1 Venture Funds
The rise in venture funds invested in start-up businesses worldwide over the past two years took a noticeable downturn in the first three months of 2022.